These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10196484)

  • 1. Improving the appropriateness of vancomycin use by sequential interventions.
    Lipsky BA; Baker CA; McDonald LL; Suzuki NT
    Am J Infect Control; 1999 Apr; 27(2):84-91. PubMed ID: 10196484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interventional program to improve antibiotic use.
    Feucht CL; Rice LB
    Ann Pharmacother; 2003 May; 37(5):646-51. PubMed ID: 12708938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
    Anglim AM; Klym B; Byers KE; Scheld WM; Farr BM
    Arch Intern Med; 1997 May; 157(10):1132-6. PubMed ID: 9164379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use.
    Singer MV; Haft R; Barlam T; Aronson M; Shafer A; Sands KE
    Infect Control Hosp Epidemiol; 1998 Apr; 19(4):248-53. PubMed ID: 9605273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin in Oregon: who's using it and why.
    Cieslak PR; Strausbaugh LJ; Fleming DW; Ling JM
    Infect Control Hosp Epidemiol; 1999 Aug; 20(8):557-60. PubMed ID: 10466557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
    Thomas AR; Cieslak PR; Strausbaugh LJ; Fleming DW
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):683-8. PubMed ID: 12452297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff.
    Richardson LP; Wiseman SW; Malani PN; Lyons MJ; Kauffman CA
    Microb Drug Resist; 2000; 6(4):327-30. PubMed ID: 11272262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence.
    Choe PG; Koo HL; Yoon D; Bae JY; Lee E; Hwang JH; Song KH; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Oh MD; Kim NJ
    BMC Infect Dis; 2018 Apr; 18(1):178. PubMed ID: 29661158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians.
    Arnold FW; McDonald LC; Smith RS; Newman D; Ramirez JA
    Infect Control Hosp Epidemiol; 2006 Apr; 27(4):378-82. PubMed ID: 16622816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines.
    Evans ME; Kortas KJ
    Infect Control Hosp Epidemiol; 1996 Jun; 17(6):356-9. PubMed ID: 8805065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin overuse in Siriraj Hospital.
    Rattanaumpawan P; Thamlikitkul V; Chokepaibulkit K; Lohsiriwat D; Aswapokee N
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S125-32. PubMed ID: 17718253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of vancomycin use in the emergency department.
    Wright SW; Wrenn KD
    Ann Emerg Med; 1998 Nov; 32(5):531-6. PubMed ID: 9795314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antibiotic order form intervention does not improve or reduce vancomycin use.
    Bolon MK; Arnold AD; Feldman HA; Goldmann DA; Wright SB
    Pediatr Infect Dis J; 2005 Dec; 24(12):1053-8. PubMed ID: 16371865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin use in a university medical center: effect of a vancomycin continuation form.
    Evans ME; Millheim ET; Rapp RP
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):417-20. PubMed ID: 10395144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, appropriateness, and cost of vancomycin use.
    Jarvis WR
    Clin Infect Dis; 1998 May; 26(5):1200-3. PubMed ID: 9597253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin use in 2 Ontario tertiary care hospitals: a survey.
    Kwan T; Lin F; Ngai B; Loeb M
    Clin Invest Med; 1999 Dec; 22(6):256-64. PubMed ID: 10664867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating vancomycin use at a pediatric hospital: new approaches and insights.
    Bolon MK; Arnold AD; Feldman HA; Rehkopf DH; Strong EF; Goldmann DA; Wright SB
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):47-55. PubMed ID: 15693408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin use in a hospital with vancomycin restriction.
    Roghmann MC; Perdue BE; Polish L
    Infect Control Hosp Epidemiol; 1999 Jan; 20(1):60-3. PubMed ID: 9927270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Hospital Infection Control Practice Advisory Committee.
    Salemi C; Becker L; Morrissey R; Warmington J
    Clin Perform Qual Health Care; 1998; 6(1):12-6. PubMed ID: 10177043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.
    Levy ER; Swami S; Dubois SG; Wendt R; Banerjee R
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):346-53. PubMed ID: 22418629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.